Sleeping Beauty transposon-based system for cellular reprogramming and targeted gene insertion in induced pluripotent stem cells

Nucleic Acids Research

Volumn 41, Issue 3, 2013, Pages 1829-1847

  Grabundzija, Ivana ^a   Wang, Jichang ^a   Sebe, Attila ^b,c   Erdei, Zsuzsanna ^b   Kajdi, Robert ^d   Devaraj, Anantharam ^a   Steinemann, Doris ^e   Szuhai, Károly ^f   Stein, Ulrike ^a   Cantz, Tobias ^e   Schambach, Axel ^e   Baum, Christopher ^e   Izsvák, Zsuzsanna ^a   Sarkadi, Balázs ^b   Ivics, Zoltán ^a,d  

^a MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

^b INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

^c UNIVERSITY OF DEBRECEN   (Hungary)

^d PAUL EHRLICH INSTITUT   (Germany)

^e HANNOVER MEDICAL SCHOOL   (Germany)

^f LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CELL PROTEIN; CRE RECOMBINASE; KRUPPEL LIKE FACTOR 4; LIN28 PROTEIN; MICRORNA; MICRORNA 302; MICRORNA 367; MYC PROTEIN; OCTAMER TRANSCRIPTION FACTOR 4; RETROVIRUS VECTOR; SLEEPING BEAUTY 100X TRANSPOSASE; TRANSCRIPTION FACTOR SOX2; TRANSPOSASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; COPY NUMBER VARIATION; DNA TRANSPOSITION; EMBRYO; EMBRYOID BODY; GENE CASSETTE; GENE CLUSTER; GENE EXPRESSION REGULATION; GENE INSERTION; GENE LOCUS; GENE TARGETING; HUMAN; HUMAN CELL; HUMAN TISSUE; KARYOTYPE; MOUSE; NONHUMAN; NUCLEAR REPROGRAMMING; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; SITE DIRECTED MUTAGENESIS; TRANSPOSON;

ANIMALS; CELL DIFFERENTIATION; CELLS, CULTURED; DNA TRANSPOSABLE ELEMENTS; GENE KNOCK-IN TECHNIQUES; GENETIC VECTORS; HELA CELLS; HUMANS; INDUCED PLURIPOTENT STEM CELLS; INTEGRASES; MICE; NUCLEAR REPROGRAMMING; TRANSPOSASES;

EID: 84873693244     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gks1305     Document Type: Article

References (71)

1. Shao,L. and Wu,W.S. (2010) Gene-delivery systems for iPS cell generation. Expert Opin. Biol. Ther., 10, 231-242.
2. Takahashi,K. and Yamanaka,S. (2006) Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell, 126, 663-676.
3. Hanna,J.H., Saha,K. and Jaenisch,R. (2010) Pluripotency and cellular reprogramming: facts, hypotheses, unresolved issues. Cell, 143, 508-525.
4. Gonzalez,F., Boue,S. and Izpisua Belmonte,J.C. (2011) Methods for making induced pluripotent stem cells: reprogramming a la carte. Nat. Rev. Genet., 12, 231-242.
5. Raya,A., Rodriguez-Piza,I., Guenechea,G., Vassena,R., Navarro,S., Barrero,M.J., Consiglio,A., Castella,M., Rio,P., Sleep,E. et al. (2009) Disease-corrected haematopoietic progenitors from Fanconi anaemia induced pluripotent stem cells. Nature, 460, 53-59.
6. Hanna,J., Wernig,M., Markoulaki,S., Sun,C.W., Meissner,A., Cassady,J.P., Beard,C., Brambrink,T., Wu,L.C., Townes,T.M. et al. (2007) Treatment of sickle cell anemia mouse model with iPS cells generated from autologous skin. Science, 318, 1920-1923.
7. Park,I.H., Arora,N., Huo,H., Maherali,N., Ahfeldt,T., Shimamura,A., Lensch,M.W., Cowan,C., Hochedlinger,K. and Daley,G.Q. (2008) Disease-specific induced pluripotent stem cells. Cell, 134, 877-886.
8. Xu,D., Alipio,Z., Fink,L.M., Adcock,D.M., Yang,J., Ward,D.C. and Ma,Y. (2009) Phenotypic correction of murine hemophilia A using an iPS cell-based therapy. Proc. Natl Acad. Sci. USA, 106, 808-813.
9. Amabile,G. and Meissner,A. (2009) Induced pluripotent stem cells: current progress and potential for regenerative medicine. Trends Mol. Med., 15, 59-68.
10. Ye,L., Chang,J.C., Lin,C., Sun,X., Yu,J. and Kan,Y.W. (2009) Induced pluripotent stem cells offer new approach to therapy in thalassemia and sickle cell anemia and option in prenatal diagnosis in genetic diseases. Proc. Natl Acad. Sci. USA, 106, 9826-9830.
11. Ye,Z., Zhan,H., Mali,P., Dowey,S., Williams,D.M., Jang,Y.Y., Dang,C.V., Spivak,J.L., Moliterno,A.R. and Cheng,L. (2009) Human-induced pluripotent stem cells from blood cells of healthy donors and patients with acquired blood disorders. Blood, 114, 5473-5480.
12. Zou,J., Maeder,M.L., Mali,P., Pruett-Miller,S.M., Thibodeau-Beganny,S., Chou,B.K., Chen,G., Ye,Z., Park,I.H., Daley,G.Q. et al. (2009) Gene targeting of a disease-related gene in human induced pluripotent stem and embryonic stem cells. Cell Stem Cell, 5, 97-110.
13. Wernig,M., Zhao,J.P., Pruszak,J., Hedlund,E., Fu,D., Soldner,F., Broccoli,V., Constantine-Paton,M., Isacson,O. and Jaenisch,R. (2008) Neurons derived from reprogrammed fibroblasts functionally integrate into the fetal brain and improve symptoms of rats with Parkinson's disease. Proc. Natl Acad. Sci. USA, 105, 5856-5861.
14. Aoi,T., Yae,K., Nakagawa,M., Ichisaka,T., Okita,K., Takahashi,K., Chiba,T. and Yamanaka,S. (2008) Generation of pluripotent stem cells from adult mouse liver and stomach cells. Science, 321, 699-702.
15. Sommer,C.A., Stadtfeld,M., Murphy,G.J., Hochedlinger,K., Kotton,D.N. and Mostoslavsky,G. (2009) Induced pluripotent stem cell generation using a single lentiviral stem cell cassette. Stem Cells, 27, 543-549.
16. Okita,K., Ichisaka,T. and Yamanaka,S. (2007) Generation of germline-competent induced pluripotent stem cells. Nature, 448, 313-317.
17. Kaji,K., Norrby,K., Paca,A., Mileikovsky,M., Mohseni,P. and Woltjen,K. (2009) Virus-free induction of pluripotency and subsequent excision of reprogramming factors. Nature, 458, 771-775.
18. Soldner F. Hockemeyer,D., Beard,C., Gao,Q., Bell,G.W., Cook,E.G., Hargus,G., Blak,A., Cooper,O., Mitalipova,M. et al. (2009) Parkinson's disease patient-derived induced pluripotent stem cells free of viral reprogramming factors. Cell, 136, 964-977.
19. Voelkel,C., Galla,M., Maetzig,T., Warlich,E., Kuehle,J., Zychlinski,D., Bode,J., Cantz,T., Schambach,A. and Baum,C. (2010) Protein transduction from retroviral Gag precursors. Proc. Natl Acad. Sci. USA, 107, 7805-7810.
20. Okita,K., Nakagawa,M., Hyenjong,H., Ichisaka,T. and Yamanaka,S. (2008) Generation of mouse induced pluripotent stem cells without viral vectors. Science, 322, 949-953.
21. Stadtfeld,M., Nagaya,M., Utikal,J., Weir,G. and Hochedlinger,K. (2008) Induced pluripotent stem cells generated without viral integration. Science, 322, 945-949.
22. Gonzalez,F., Barragan Monasterio,M., Tiscornia,G., Montserrat Pulido,N., Vassena,R., Batlle Morera,L., Rodriguez Piza,I. and Izpisua Belmonte,J.C. (2009) Generation of mouse-induced pluripotent stem cells by transient expression of a single nonviral polycistronic vector. Proc. Natl Acad. Sci. USA, 106, 8918-8922.
23. Huangfu,D., Osafune,K., Maehr,R., Guo,W., Eijkelenboom,A., Chen,S., Muhlestein,W. and Melton,D.A. (2008) Induction of pluripotent stem cells from primary human fibroblasts with only Oct4 and Sox2. Nat. Biotechnol., 26, 1269-1275.
24. Fusaki,N., Ban,H., Nishiyama,A., Saeki,K. and Hasegawa,M. (2009) Efficient induction of transgene-free human pluripotent stem cells using a vector based on Sendai virus, an RNA virus that does not integrate into the host genome. Proc. Jpn. Acad. Ser. B Phys. Biol. Sci., 85, 348-362.
25. Seki,T., Yuasa,S., Oda,M., Egashira,T., Yae,K., Kusumoto,D., Nakata,H., Tohyama,S., Hashimoto,H., Kodaira,M. et al. (2010) Generation of induced pluripotent stem cells from human terminally differentiated circulating T cells. Cell Stem Cell, 7, 11-14.
26. Yu,J., Hu,K., Smuga-Otto,K., Tian,S., Stewart,R., Slukvin,I.I. and Thomson,J.A. (2009) Human induced pluripotent stem cells free of vector and transgene sequences. Science, 324, 797-801.
27. Jia,F., Wilson,K.D., Sun,N., Gupta,D.M., Huang,M., Li,Z., Panetta,N.J., Chen,Z.Y., Robbins,R.C., Kay,M.A. et al. (2010) A nonviral minicircle vector for deriving human iPS cells. Nat. Methods, 7, 197-199.
28. Warren,L., Manos,P.D., Ahfeldt,T., Loh,Y.H., Li,H., Lau,F., Ebina,W., Mandal,P.K., Smith,Z.D., Meissner,A. et al. (2010) Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA. Cell Stem Cell, 7, 618-630.
29. Anokye-Danso,F., Trivedi,C.M., Juhr,D., Gupta,M., Cui,Z., Tian,Y., Zhang,Y., Yang,W., Gruber,P.J., Epstein,J.A. et al. (2011) Highly efficient miRNA-mediated reprogramming of mouse and human somatic cells to pluripotency. Cell Stem Cell, 8, 376-388.
30. Zhou,H., Wu,S., Joo,J.Y., Zhu,S., Han,D.W., Lin,T., Trauger,S., Bien,G., Yao,S., Zhu,Y. et al. (2009) Generation of induced pluripotent stem cells using recombinant proteins. Cell Stem Cell, 4, 381-384.
31. Kim,D., Kim,C.H., Moon,J.I., Chung,Y.G., Chang,M.Y., Han,B.S., Ko,S., Yang,E., Cha,K.Y., Lanza,R. et al. (2009) Generation of human induced pluripotent stem cells by direct delivery of reprogramming proteins. Cell Stem Cell, 4, 472-476.
32. Ivics,Z., Li,M.A., Mates,L., Boeke,J.D., Nagy,A., Bradley,A. and Izsvak,Z. (2009) Transposon-mediated genome manipulation in vertebrates. Nat. Methods, 6, 415-422.
33. Zayed,H., Izsvak,Z., Walisko,O. and Ivics,Z. (2004) Development of hyperactive sleeping beauty transposon vectors by mutational analysis. Mol. Ther., 9, 292-304.
34. Woltjen,K., Michael,I.P., Mohseni,P., Desai,R., Mileikovsky,M., Hamalainen,R., Cowling,R., Wang,W., Liu,P., Gertsenstein,M. et al. (2009) piggyBac transposition reprograms fibroblasts to induced pluripotent stem cells. Nature, 458, 766-770.
35. Yusa,K., Rad,R., Takeda,J. and Bradley,A. (2009) Generation of transgene-free induced pluripotent mouse stem cells by the piggyBac transposon. Nat. Methods, 6, 363-369.
36. Ivics,Z. Hackett,P.B., Plasterk,R.H. and Izsvak,Z. (1997) Molecular reconstruction of Sleeping Beauty, a Tc1-like transposon from fish, and its transposition in human cells. Cell, 91, 501-510.
37. Mates,L., Chuah,M.K., Belay,E., Jerchow,B., Manoj,N., Acosta-Sanchez,A., Grzela,D.P., Schmitt,A., Becker,K., Matrai,J. et al. (2009) Molecular evolution of a novel hyperactive Sleeping Beauty transposase enables robust stable gene transfer in vertebrates. Nat. Genet., 41, 753-761.
38. Grabundzija,I., Irgang,M., Mates,L., Belay,E., Matrai,J., Gogol-Doring,A., Kawakami,K., Chen,W., Ruiz,P., Chuah,M.K. et al. (2010) Comparative analysis of transposable element vector systems in human cells. Mol. Ther., 18, 1200-1209.
39. Ammar,I., Gogol-Doring,A., Miskey,C., Chen,W., Cathomen,T., Izsvak,Z. and Ivics,Z. (2012) Retargeting transposon insertions by the adeno-associated virus Rep protein. Nucleic Acids Res., 40, 6693-6712.
40. Cadinanos,J. and Bradley,A. (2007) Generation of an inducible and optimized piggyBac transposon system. Nucleic Acids Res., 35, e87.
41. Moldt,B., Yant,S.R., Andersen,P.R., Kay,M.A. and Mikkelsen,J.G. (2007) Cis-acting gene regulatory activities in the terminal regions of sleeping beauty DNA transposon-based vectors. Hum. Gene Ther., 18, 1193-1204.
42. Walisko,O., Schorn,A., Rolfs,F., Devaraj,A., Miskey,C., Izsvak,Z. and Ivics,Z. (2008) Transcriptional activities of the Sleeping Beauty transposon and shielding its genetic cargo with insulators. Mol. Ther., 16, 359-369.
43. Newman,J.C., Bailey,A.D., Fan,H.Y., Pavelitz,T. and Weiner,A.M. (2008) An abundant evolutionarily conserved CSB-PiggyBac fusion protein expressed in Cockayne syndrome. PLoS Genet., 4, e1000031.
44. Baker,M. (2009) Stem cells: fast and furious. Nature, 458, 962-965.
45. Szymczak,A.L., Workman,C.J., Wang,Y., Vignali,K.M., Dilioglou,S., Vanin,E.F. and Vignali,D.A. (2004) Correction of multi-gene deficiency in vivo using a single 'self-cleaving' 2A peptide-based retroviral vector. Nat. Biotechnol., 22, 589-594.
46. Hotta,A., Cheung,A.Y., Farra,N., Vijayaragavan,K., Seguin,C.A., Draper,J.S., Pasceri,P., Maksakova,I.A., Mager,D.L., Rossant,J. et al. (2009) Isolation of human iPS cells using EOS lentiviral vectors to select for pluripotency. Nat. Methods, 6, 370-376.
47. Szabo,P.E., Hubner,K., Scholer,H. and Mann,J.R. (2002) Allele-specific expression of imprinted genes in mouse migratory primordial germ cells. Mech. Dev., 115, 157-160.
48. Sheridan,S.D., Surampudi,V. and Rao,R.R. (2012) Analysis of embryoid bodies derived from human induced pluripotent stem cells as a means to assess pluripotency. Stem Cells Int., 2012, 738910.
49. Yoshimizu,T., Sugiyama,N., De Felice,M., Yeom,Y.I., Ohbo,K., Masuko,K., Obinata,M., Abe,K., Scholer,H.R. and Matsui,Y. (1999) Germline-specific expression of the Oct-4/green fluorescent protein (GFP) transgene in mice. Dev. Growth Differ., 41, 675-684.
50. Huangfu,D., Maehr,R., Guo,W., Eijkelenboom,A., Snitow,M., Chen,A.E. and Melton,D.A. (2008) Induction of pluripotent stem cells by defined factors is greatly improved by small-molecule compounds. Nat. Biotechnol., 26, 795-797.
51. Garrels,W., Mates,L., Holler,S., Dalda,A., Taylor,U., Petersen,B., Niemann,H., Izsvak,Z., Ivics,Z. and Kues,W.A. Germline transgenic pigs by Sleeping Beauty transposition in porcine zygotes and targeted integration in the pig genome. PloS One, 6, e23573.
52. Maksakova,I.A. and Mager,D.L. (2005) Transcriptional regulation of early transposon elements, an active family of mouse long terminal repeat retrotransposons. J. Virol., 79, 13865-13874.
53. Subramanyam,D., Lamouille,S., Judson,R.L., Liu,J.Y., Bucay,N., Derynck,R. and Blelloch,R. (2011) Multiple targets of miR-302 and miR-372 promote reprogramming of human fibroblasts to induced pluripotent stem cells. Nat. Biotechnol., 29, 443-448.
54. Chin,M.H., Mason,M.J., Xie,W., Volinia,S., Singer,M., Peterson,C., Ambartsumyan,G., Aimiuwu,O., Richter,L., Zhang,J. et al. (2009) Induced pluripotent stem cells and embryonic stem cells are distinguished by gene expression signatures. Cell Stem Cell, 5, 111-123.
55. Dimos,J.T., Rodolfa,K.T., Niakan,K.K., Weisenthal,L.M., Mitsumoto,H., Chung,W., Croft,G.F., Saphier,G., Leibel,R., Goland,R. et al. (2008) Induced pluripotent stem cells generated from patients with ALS can be differentiated into motor neurons. Science, 321, 1218-1221.
56. Ebert,A.D., Yu,J., Rose,F.F. Jr, Mattis,V.B., Lorson,C.L., Thomson,J.A. and Svendsen,C.N. (2009) Induced pluripotent stem cells from a spinal muscular atrophy patient. Nature, 457, 277-280.
57. Xue,X., Huang,X., Nodland,S.E., Mates,L., Ma,L., Izsvak,Z., Ivics,Z., LeBien,T.W., McIvor,R.S., Wagner,J.E. et al. (2009) Stable gene transfer and expression in cord blood-derived CD34++ hematopoietic stem and progenitor cells by a hyperactive Sleeping Beauty transposon system. Blood, 114, 1319-1330.
58. Hackett,P.B., Largaespada,D.A. and Cooper,L.J. (2010) A transposon and transposase system for human application. Mol. Ther., 18, 674-683.
59. Belay,E., Matrai,J., Acosta-Sanchez,A., Ma,L., Quattrocelli,M., Mates,L., Sancho-Bru,P., Geraerts,M., Yan,B., Vermeesch,J. et al. (2010) Novel hyperactive transposons for genetic modification of induced pluripotent and adult stem cells: a nonviral paradigm for coaxed differentiation. Stem Cells, 28, 1760-1771.
60. Jin,Z., Maiti,S., Huls,H., Singh,H., Olivares,S., Mates,L., Izsvak,Z., Ivics,Z., Lee,D.A., Champlin,R.E. et al. (2011) The hyperactive Sleeping Beauty transposase SB100X improves the genetic modification of T cells to express a chimeric antigen receptor. Gene Ther., 18, 849-856.
61. Wang,Y., Chen,J., Hu,J.L., Wei,X.X., Qin,D., Gao,J., Zhang,L., Jiang,J., Li,J.S., Liu,J. et al. (2011) Reprogramming of mouse and human somatic cells by high-performance engineered factors. EMBO Rep., 12, 373-378.
62. Qiu,C., Ma,Y., Wang,J., Peng,S. and Huang,Y. (2010) Lin28-mediated post-transcriptional regulation of Oct4 expression in human embryonic stem cells. Nucleic Acids Res., 38, 1240-1248.
63. Warlich,E., Kuehle,J., Cantz,T., Brugman,M.H., Maetzig,T., Galla,M., Filipczyk,A.A., Halle,S., Klump,H., Scholer,H.R. et al. (2011) Lentiviral vector design and imaging approaches to visualize the early stages of cellular reprogramming. Mol. Ther., 19, 782-789.
64. Kim,H., Lee,G., Ganat,Y., Papapetrou,E.P., Lipchina,I., Socci,N.D., Sadelain,M. and Studer,L. (2011) miR-371-3 expression predicts neural differentiation propensity in human pluripotent stem cells. Cell Stem Cell, 8, 695-706.
65. Li,Z., Yang,C.S., Nakashima,K. and Rana,T.M. (2011) Small RNA-mediated regulation of iPS cell generation. EMBO J., 30, 823-834.
66. Lipchina,I., Elkabetz,Y., Hafner,M., Sheridan,R., Mihailovic,A., Tuschl,T., Sander,C., Studer,L. and Betel,D. (2011) Genome-wide identification of microRNA targets in human ES cells reveals a role for miR-302 in modulating BMP response. Genes Dev., 25, 2173-2186.
67. Leung,A.K., Young,A.G., Bhutkar,A., Zheng,G.X., Bosson,A.D., Nielsen,C.B. and Sharp,P.A. (2011) Genome-wide identification of Ago2 binding sites from mouse embryonic stem cells with and without mature microRNAs. Nat. Struct. Mol. Biol., 18, 237-244.
68. Tesar,P.J., Chenoweth,J.G., Brook,F.A., Davies,T.J., Evans,E.P., Mack,D.L., Gardner,R.L. and McKay,R.D. (2007) New cell lines from mouse epiblast share defining features with human embryonic stem cells. Nature, 448, 196-199.
69. Brons,I.G., Smithers,L.E., Trotter,M.W., Rugg-Gunn,P., Sun,B., Chuva de Sousa Lopes,S.M., Howlett,S.K., Clarkson,A., Ahrlund-Richter,L., Pedersen,R.A. et al. (2007) Derivation of pluripotent epiblast stem cells from mammalian embryos. Nature, 448, 191-195.
70. Nichols,J. and Smith,A. (2009) Naive and primed pluripotent states. Cell Stem Cell, 4, 487-492.
71. Jouneau,A., Ciaudo,C., Sismeiro,O., Brochard,V., Jouneau,L., Vandormael-Pournin,S., Coppee,J.Y., Zhou,Q., Heard,E., Antoniewski,C. et al. (2012) Naive and primed murine pluripotent stem cells have distinct miRNA expression profiles. RNA, 18, 253-264.